Design
Review
Authors
Loading...
Should not change clinical practice; leaves open phospholamban as a mechanistic target for future trials.
Key points are not available for this paper at this time.
Karczewski et al. (1993) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: